Phenotypical manifestations of biological diversity of escherichia coli clinical isolates

Authors

  • Юлія Валеріївна Войда Kharkov Medical Academy of Postgraduate Education 58 Korchagincev str., Kharkov, Ukraine, 61000, Ukraine

DOI:

https://doi.org/10.15587/2313-8416.2015.51835

Keywords:

Escherichia coli, biological properties, biotope, hemolytic activity, antibiotics, antibiotic resistance, β-lactamases

Abstract

Aim. The study biological properties of E. coli clinical isolates and ascertainment the prevalence of clinically important polyresistant strains among them.

Methods. There were studied morphological, cultural, biochemical properties and also several factors of aggression (hemolytic activity, antibiotic resistance) of 667 E. Сoli clinical strains extracted from the different biotypes.

Result. There was established that isolates of colon bacillus with hemolytic phenotype took place in all analyzed groups, the frequency of detection depended on pyoinflammatory process. There was established high sensitivity of Escherichia hemolytic strains to imipenem, gatifloxacin and amikacin that prove its practical importance as reserve preparations for treatment Escherichia infections caused with polyresistant strains. There was detected an increase of resistance to fluorquinolones and circulation of the great amount of strains moderately resistant to derivative nitrofurans and nitroxolinums that play a leading role in schemes of long empirical therapy of patients with chronic pyelonephritis.

Conclusions. An associated hemolytic activity and antibiotic resistance in bio-profile of specific microorganism give it bio-aggression and make it potentially able to overcome the owner’s system of immune protection and to cause an abenteric infection. The high prevalence of antibiotic resistance among extracted isolates – representatives of the normal microflora – makes it a potential source of the spread of resistant determinants among population of its own and allied species of bacteria of different taxonomic groups. It is reasonable to carry out periodic monitoring in medical institutions for timely improvement of schemes of empirical therapy of infection of Escherichia etiology

Author Biography

Юлія Валеріївна Войда, Kharkov Medical Academy of Postgraduate Education 58 Korchagincev str., Kharkov, Ukraine, 61000

Docent, PhD in biological sciences

Department of clinical immunology and microbiology

References

Voyda, Ju. V. (2013). Fenotipovij polіmorfіzm і genetichna plastichnіst' shtamіv Escherichia coli rіznih bіotopіv ta zberezhenіst' ih bіologіchnih vlastivostej krіokonservuvannjam. HMAPO MOZ Ukrayni, Kharkiv, 23.

Jaureguy, F., Landraud, L., Passet, V., Diancourt, L., Frapy, E., Guigon, G. et. al (2008). Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics, 9 (1), 560. doi: 10.1186/1471-2164-9-560

Behalo, V. M., Bondarenko, V. M., Sysoljatina, E. V. (2009). Harakter vzaimodejstvija bakterij-kommensalov s faktorami immuniteta pri nekotoryh sindromah hronicheskogo vospalenija kishechnika. Farmateka, 13, 20–25.

Mihajlova, L. V., Kramar', V. O., Savchenko, T. N., Klimova, T. N. (2010). Faktory, sposobstvujushhie persistencii uslovno-patogennyh mikroorganizmov. Vestnik VolGMU, 4 (36), 76–79.

Salmanov, A. G., Khobzey, M. K., Marіyevs'kiy, V. F. (2011). Antibіotikorezystentnіst' klіnіchnykh shtamіv Escherichia coli v khіrurgіchnykh statsіonarakh Ukrainy v 2010 r. Ukr. medych. Chasopys, 4 (84), 124–128. Available at: http://zarifacenter.org/articles/article097.pdf

Patel, T., Levitin, A. (2014). Escherichia Coli Adaptive Resistance to Clinical Antibiotics. JSM Microbiology, 2 (1), 1–5. Available at: http://www.jscimedcentral.com/Microbiology/microbiology-2-1007.pdf

Shljapnikov, S. A., Naser, N. R., Popenko, L. N. (2009). Profil' antibiotikorezistentnosti osnovnyh vozbuditelej gospital'nyh infekcij v ORIT mnogoprofil'nogo stacionara. Infekcii v hirurgii, 7 (1), 8–11.

Ob unifikacii mikrobiologicheskih (bakteriologicheskih) metodov issledovanija, primenjaemyh v kliniko-diagnosticheskih laboratorijah lechebno-profilakticheskih uchrezhdenij (1985). Prikaz MOZ SSSR № 535 ot 22.04.1985. Moscow, 65.

Labinskoy, A. S., Blinkovoy, L. P., Eshchinoy, A. S. (Eds.) (2005). Chastnaya meditsinskaya mikrobiologiya s tekhnikoy mikrobiologicheskikh issledovaniy. Moscow: Meditsina, 600.

Garrity, G. M. (Ed.) (2005). Genus I. Escherichia in The Gammaproteobacteria. Bergey’s Manual of Systematic Bacteriology. Bergey's Manual Trust: Springer, 2, 607–624. doi: 10.1007/0-387-28022-7

Pro zatverdzhennya metodychnykh vkazіvok shchodo vyznachennya chutlyvostі mіkroorganіzmіv do antybakterіal'nykh preparatіv (2007). Nakaz MOZ Ukrainy № 167 vіd 05.04.2007. Kyiv, 63.

Smirnov, A. V., Kajukov, I. G. (2006). Mesto nitrofuranov v sovremennoj terapii infekcij mochevyh putej. Nefrologija, 10 (4), 103–113.

Jankovskij, D. S. (2005). Mikrobnaja jekologija cheloveka: sovremennye vozmozhnosti ee podderzhanija i vosstanovlenija. Kyiv: Jekspert LTD, 362.

Rafal'skij, V. V., Hodnevich, L. V. (2008). Vlijanie rezistentnosti vozbuditelej infekcij mochevyvodjashhih putej na ishody antibakterial'noj terapii. Urologija, 4, 3–9.

Published

2015-10-30

Issue

Section

Medical Science. Part 2